N-(Triphenylmethyl)-5-(4-Bromomethylbiphenyl-2-yl-)Tetrazole

We are N-(Triphenylmethyl)-5-(4-Bromomethylbiphenyl-2-yl-)Tetrazole CAS:124750-51-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: N-(Triphenylmethyl)-5-(4-Bromomethylbiphenyl-2-yl-)Tetrazole
CAS.NO: 124750-51-2
Synonyms: 
5-[2-[4-(bromomethyl)phenyl]phenyl]-1-trityltetrazole
5-(4'-(BROMOMETHYL)(1,1'-BIPHENYL)-2-YL)-1-TRITYL-1H-TETRAAZOLE
N-(Triphenylmethyl)-5-(4-bromomethylbiphenyl-2-yl)tetrazole
5-(4'-(Bromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
5-[4’-Bromomethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole

Molecular Formula: C33H25BrN4
Molecular Weight: 557.48200

Physical and Chemical Properties:
Density: 1.282 g / cm3
Boiling point: 718.441ºC at 760 mmHg
Melting point: 152-155ºC
Flash point: 388.299ºC
Refractive index: 1.66

Specification:
Appearance: White powder
Purity:≥97%
Loss on drying:≤1% 

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Olmesartan medoxomil CAS:144689-63-4
Intermediates of Valsartan  CAS:137862-53-4
Intermediates of Olmesartan CAS:144689-24-7

Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.1,2-Dibromobutane CAS:533-98-2 The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.2-methyl-5-(trifluoromethyl)aniline CAS:25449-96-1 The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.Fenil clorotionocarbonato CAS:1005-56-7 This includes chemical APIs.This includes chemical APIs.